Masimo ROA 2010-2024 | MASI
Current and historical return on assets (ROA) values for Masimo (MASI) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Masimo ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2024-09-30 | $0.08B | $3.09B | 2.64% |
| 2024-06-30 | $0.08B | $2.89B | 2.69% |
| 2024-03-31 | $0.08B | $2.96B | 2.67% |
| 2023-12-31 | $0.08B | $3.04B | 2.70% |
| 2023-09-30 | $0.09B | $3.00B | 2.89% |
| 2023-06-30 | $0.12B | $3.01B | 3.74% |
| 2023-03-31 | $0.12B | $3.12B | 3.82% |
| 2022-12-31 | $0.14B | $3.21B | 5.17% |
| 2022-09-30 | $0.17B | $3.06B | 6.97% |
| 2022-06-30 | $0.19B | $2.96B | 8.96% |
| 2022-03-31 | $0.22B | $1.91B | 12.31% |
| 2021-12-31 | $0.23B | $1.89B | 13.21% |
| 2021-09-30 | $0.23B | $1.77B | 13.73% |
| 2021-06-30 | $0.22B | $1.68B | 13.30% |
| 2021-03-31 | $0.23B | $1.60B | 13.75% |
| 2020-12-31 | $0.24B | $1.71B | 14.69% |
| 2020-09-30 | $0.22B | $1.71B | 14.28% |
| 2020-06-30 | $0.22B | $1.64B | 15.26% |
| 2020-03-31 | $0.21B | $1.48B | 15.59% |
| 2019-12-31 | $0.20B | $1.40B | 15.32% |
| 2019-09-30 | $0.19B | $1.31B | 15.58% |
| 2019-06-30 | $0.20B | $1.23B | 17.00% |
| 2019-03-31 | $0.20B | $1.18B | 17.76% |
| 2018-12-31 | $0.19B | $1.16B | 18.44% |
| 2018-09-30 | $0.14B | $1.10B | 14.05% |
| 2018-06-30 | $0.12B | $1.01B | 12.53% |
| 2018-03-31 | $0.12B | $0.95B | 13.02% |
| 2017-12-31 | $0.13B | $0.91B | 13.95% |
| 2017-09-30 | $0.36B | $0.91B | 41.02% |
| 2017-06-30 | $0.35B | $0.90B | 43.41% |
| 2017-03-31 | $0.34B | $0.88B | 45.70% |
| 2016-12-31 | $0.31B | $0.82B | 46.50% |
| 2016-09-30 | $0.11B | $0.64B | 17.85% |
| 2016-06-30 | $0.10B | $0.60B | 16.81% |
| 2016-03-31 | $0.09B | $0.62B | 15.09% |
| 2015-12-31 | $0.08B | $0.60B | 14.19% |
| 2015-09-30 | $0.08B | $0.58B | 13.90% |
| 2015-06-30 | $0.08B | $0.58B | 13.48% |
| 2015-03-31 | $0.07B | $0.58B | 13.08% |
| 2014-12-31 | $0.07B | $0.57B | 14.21% |
| 2014-09-30 | $0.06B | $0.53B | 12.65% |
| 2014-06-30 | $0.06B | $0.50B | 13.59% |
| 2014-03-31 | $0.07B | $0.46B | 15.09% |
| 2013-12-31 | $0.06B | $0.44B | 14.04% |
| 2013-09-30 | $0.06B | $0.43B | 16.12% |
| 2013-06-30 | $0.06B | $0.40B | 15.80% |
| 2013-03-31 | $0.06B | $0.39B | 16.22% |
| 2012-12-31 | $0.06B | $0.38B | 16.30% |
| 2012-09-30 | $0.06B | $0.41B | 16.14% |
| 2012-06-30 | $0.06B | $0.38B | 16.79% |
| 2012-03-31 | $0.06B | $0.38B | 16.85% |
| 2011-12-31 | $0.06B | $0.37B | 18.03% |
| 2011-09-30 | $0.07B | $0.37B | 19.35% |
| 2011-06-30 | $0.07B | $0.35B | 20.35% |
| 2011-03-31 | $0.06B | $0.33B | 20.22% |
| 2010-12-31 | $0.07B | $0.31B | 23.76% |
| 2010-09-30 | $0.07B | $0.33B | 22.27% |
| 2010-06-30 | $0.07B | $0.30B | 21.18% |
| 2010-03-31 | $0.07B | $0.29B | 20.63% |
| 2009-12-31 | $0.05B | $0.36B | 16.15% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $9.509B | $2.048B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $217.348B | 26.52 |
| Intuitive Surgical (ISRG) | United States | $203.988B | 93.58 |
| Alcon (ALC) | Switzerland | $45.073B | 30.16 |
| Edwards Lifesciences (EW) | United States | $41.952B | 26.64 |
| IQVIA Holdings (IQV) | United States | $35.950B | 19.81 |
| IDEXX Laboratories (IDXX) | United States | $34.289B | 40.38 |
| DexCom (DXCM) | United States | $33.759B | 50.84 |
| Waters (WAT) | United States | $23.998B | 35.49 |
| STERIS (STE) | Ireland | $21.743B | 25.03 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.798B | 0.00 |
| Hologic (HOLX) | United States | $16.119B | 17.50 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.577B | 14.96 |
| Globus Medical (GMED) | United States | $12.635B | 32.00 |
| Sysmex ADR (SSMXY) | Japan | $12.243B | 38.39 |
| Penumbra (PEN) | United States | $10.352B | 101.40 |
| Glaukos (GKOS) | United States | $8.767B | 0.00 |
| Teleflex (TFX) | United States | $8.387B | 13.38 |
| Integer Holdings (ITGR) | United States | $4.804B | 27.23 |
| Inari Medical (NARI) | United States | $4.666B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $3.807B | 0.00 |
| Veracyte (VCYT) | United States | $3.444B | 103.35 |
| LivaNova (LIVN) | United Kingdom | $2.755B | 15.90 |
| Nihon Kohden (NHNKY) | Japan | $2.554B | 19.40 |
| Tandem Diabetes Care (TNDM) | United States | $2.388B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.309B | 20.76 |
| TransMedics (TMDX) | United States | $2.199B | 69.71 |
| Integra LifeSciences Holdings (IART) | United States | $2.016B | 10.53 |
| Alphatec Holdings (ATEC) | United States | $1.710B | 0.00 |
| Artivion (AORT) | United States | $1.309B | 86.72 |
| RxSight (RXST) | United States | $1.273B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.214B | 0.00 |
| Paragon 28 (FNA) | United States | $1.088B | 0.00 |
| OPKO Health (OPK) | United States | $1.024B | 0.00 |
| AxoGen (AXGN) | United States | $0.806B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.795B | 13.51 |
| IRadimed (IRMD) | United States | $0.759B | 40.99 |
| Mesa Laboratories (MLAB) | United States | $0.743B | 17.51 |
| SiBone (SIBN) | United States | $0.722B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.715B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.649B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.602B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.504B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.500B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.491B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.483B | 25.41 |
| NeuroPace (NPCE) | United States | $0.438B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.429B | 23.23 |
| Pacific Biosciences Of California (PACB) | United States | $0.427B | 0.00 |
| CVRx (CVRX) | United States | $0.409B | 0.00 |
| Inogen (INGN) | United States | $0.298B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.255B | 0.00 |
| Accuray (ARAY) | United States | $0.223B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.214B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.197B | 0.00 |
| Nevro (NVRO) | United States | $0.190B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.155B | 0.00 |
| LENSAR (LNSR) | United States | $0.129B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.110B | 11.75 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.105B | 0.00 |
| Neuronetics (STIM) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.096B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.085B | 0.00 |
| 908 Devices (MASS) | United States | $0.082B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.076B | 0.00 |
| Hyperfine (HYPR) | United States | $0.072B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.069B | 0.00 |
| InspireMD (NSPR) | Israel | $0.063B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.059B | 30.86 |
| EnVVeno Medical (NVNO) | United States | $0.055B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.053B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.046B | 0.00 | |
| Microbot Medical (MBOT) | United States | $0.036B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.036B | 0.00 |
| Spectral AI (MDAI) | United States | $0.034B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| DarioHealth (DRIO) | United States | $0.022B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Tenon Medical (TNON) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |